Basics |
Aquestive Therapeutics, Inc.
|
IPO Date: |
July 23, 2018 |
Sector: |
Healthcare |
Industry: |
Drug Manufacturers - Specialty and Generic |
Market Cap: |
$283.08M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.16 | 3.74%
|
Avg Daily Range (30 D): |
$0.09 | 3.42%
|
Avg Daily Range (90 D): |
$0.10 | 3.39%
|
Institutional Daily Volume |
Avg Daily Volume: |
.69M |
Avg Daily Volume (30 D): |
1.45M |
Avg Daily Volume (90 D): |
1.48M |
Trade Size |
Avg Trade Size (Sh.): |
184 |
Avg Trade Size (Sh.) (30 D): |
179 |
Avg Trade Size (Sh.) (90 D): |
188 |
Institutional Trades |
Total Inst.Trades: |
120 |
Avg Inst. Trade: |
$1.97M |
Avg Inst. Trade (30 D): |
$.7M |
Avg Inst. Trade (90 D): |
$2.85M |
Avg Inst. Trade Volume: |
.5M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.21M |
Avg Closing Trade (30 D): |
$.74M |
Avg Closing Trade (90 D): |
$.8M |
Avg Closing Volume: |
518.76K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.59
|
$-.24
|
$-.19
|
Diluted EPS
|
$-.59
|
$-.24
|
$-.19
|
Revenue
|
$ 54.23M
|
$ 8.72M
|
$ 11.87M
|
Gross Profit
|
$ 37.09M
|
$ 5.07M
|
$ 7.35M
|
Net Income / Loss
|
$ -54.24M
|
$ -22.93M
|
$ -17.06M
|
Operating Income / Loss
|
$ -41.18M
|
$ -19.37M
|
$ -13.58M
|
Cost of Revenue
|
$ 17.14M
|
$ 3.65M
|
$ 4.52M
|
Net Cash Flow
|
$ -26.54M
|
$ -2.89M
|
$ -6.35M
|
PE Ratio
|
|
|
|
|